While Pfizer has made a number of acquisitions, its biggest bet is on Seagen. Pfizer wants this to be a transformative acquisition, and it projects Seagen to contribute $10 billion in sales by 2030.

Pfizer CEO Albert Bourla plans to meet key executives of activist hedge fund Starboard Value next week, the Financial Times ...

The Roundhill Magnificent Seven ETF — which holds Big Tech stocks including Nvidia, Apple Inc., Microsoft Corp, Alphabet Inc.

Nurix Therapeutics offers promising targeted protein degradation treatments for cancer and autoimmune diseases. Find out what ...

Pfizer's stock is poised for growth with strong technical and fundamental indicators, promising pipeline, and Seagen ...

Activist investor Starboard has taken a $1 billion stake in Pfizer, according to a report, Super Micro stock surges, and ...

Stocks fell as traders trimmed their bets on Federal Reserve rate cuts, sending Treasury 10-year yields above 4%. Oil rallied ...

Evan Seigerman, an analyst from BMO Capital, maintained the Buy rating on Pfizer (PFE – Research Report). The associated price target ...

Pfizer Inc. (PFE) is currently at $29.69, up $1.11 or 3.88% --Would be highest close since Sept. 18, 2024, when it closed at $29.75 --On pace for largest percent increase since May 1, 2024, when it ...

J.P. Morgan analyst Chris Schott maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $30.00. The ...

Activist investor Starboard Value has taken a roughly $1 billion stake in Pfizer and wants the struggling drugmaker to make changes to turn its performance around, [The Wall Street Journal reported]( ...